Navigation Links
goBalto Partners with Maya Clinicals to Expand Its List of Investigator Sites

Leading India-based Investigator Sites Now Available on

San Francisco, CA (PRWEB) May 19, 2009 -- goBalto, an online drug development partnering site for the pharmaceutical development and drug manufacturing industry, announced today that Maya Clinicals is making its proprietary list of India-based Investigator Sites and hospitals available on

Maya Clinicals is a leading Clinical Research Organization (CRO) in India, one of the foremost countries for clinical trials outsourcing. Its proprietary list of Investigator Sites listed on goBalto is divided into two categories: "Sourced by Maya Clinicals" and "Screened by Maya Clinicals." "Sourced by" indicates Maya Clinicals has identified these Investigator Sites as actively operating in India and maintains information on the company. "Screened by" indicates Maya Clinicals has visited the facility, met with senior management and reviewed the company's specific capabilities.

Since launching in April, goBalto has acquired over 2,000 members who represent, research, manufacturing and procurement professionals from leading pharmaceutical and biotech organizations from all over the world.

According to a recent PricewaterhouseCoopers study, the CRO market in India was $323 million in 2007. Largely driven by outsourcing from international firms, it is projected to grow at an estimated 49 percent annually, bringing the market to nearly $900 million in 2010. The global CRO market is growing at a far slower 12.6 percent per year.

"Acquiring Maya Clinicals' proprietary list is a great opportunity for the goBalto community," said Jae Chung, founder and CEO, goBalto. "Unless you've been actively conducting trials, it is quite challenging for drug development professionals, unfamiliar with India's outsourcing industry, to find qualified Investigator Sites there. By interfacing Maya Clinicals' list to our platform, users will be able to more quickly and easily evaluate the leading Investigator Sites in the region and become informed about the exciting, high-growth Indian market."

"We were delighted to see goBalto launch its drug development partnering platform last month and to observe its initial rapid growth," said Mahdav Rheddy, President of Maya Clinicals. "Over the past five years we have gathered an extensive network of hospitals, principal investigators and CRAs for Phase I and Phase IV clinical trials. Our partnership with goBalto will help them extend and deepen their reach with pharmaceutical and biotech companies."

Maya Clinicals' list adds India-based Investigator Sites to the list of over 7,000 potential service providers goBalto has assembled and profiled based on technical expertise, facilities, commercial terms and quality. The goBalto platform allows users to rate companies, post comments to vendors and evaluate service providers

About goBalto
goBalto is a dedicated online drug development partnering site for the pharmaceutical and drug manufacturing industry. Users can identify, evaluate, and manage drug-development partners from around the world. Incorporating the latest in Web 2.0 technologies, goBalto's platform enables users to distinguish their offerings by adding logos, images, videos, customer testimonials and post referrals from members. More than 7,000 service providers are currently listed.

About Maya Clinicals
Maya Clinicals is a biotechnology contract research company dedicated to accelerating the new drug development processes and reducing the barriers to new therapeutics development. Maya Clinicals offers comprehensive customer solutions to address the entire clinical trials process from initial IND submission through the clinical trials to final report submission to the FDA. The company is headquartered in Northern California with facilities in Hyderabad, India.

Press contacts:
Jamie O'Donnell
Jamie.odonnell (at) seo-pr (dot) com
Phone 415 606 5914

press (at) gobalto (dot) com
Phone 415 671 4372

For marketing opportunities, contact:
Erik Sam
goBalto, Director of Business Development
esam (at) gobalto (dot) com
Phone 415 671 4372


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Solvay Pharmaceuticals Announces Strategic Partnership With HUYA to Access new Drug Candidates From China
2. Scotland Highlights New Partnerships and Cutting-Edge Drug Discovery Research
3. Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners
4. The Institut Pasteur and Merieux Alliance Take First Step Towards a Long-Term Research Partnership in the Field of Infectious Diseases
5. Ambry Genetics Announces the Addition of Array CGH Services Through Partnership With Baylor College of Medicine
6. SynCo Bio Partners Wins Best Contract Manufacturing Organization 2009 ViE Award
7. Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities
8. DATATRAK International, Inc. Forms Strategic Partnership with Inclinix, Inc.
9. ImQuest BioSciences and Arisyn Therapeutics Announce Strategic Partnership to Develop Infectious Disease and Cancer Drugs
10. DecisionQ Partners With Thomas Jefferson University to Reveal Insights for Cancer Therapy
11. E&K Scientific Announces Partnership with Sciformatix
Post Your Comments:
(Date:11/30/2015)... , Nov. 30, 2015 /PRNewswire/ - Zenith Epigenetics Corp. ... Dr. Norman C.W. Wong to its Board of ... comes to Zenith with a wealth of experience as co-founder ... molecular biology. --> --> ... Zenith Epigenetics, board of directors. Zenith,s long standing expertise in ...
(Date:11/30/2015)... 2015  Champions Oncology, Inc. (CSBR), engaged in the ... the development and use of oncology drugs, today announced ... be presenting at the LD MICRO Investor Conference on ... (PST).  The conference, held at the Luxe Sunset Bel ... , will feature 200 small/micro-cap companies and is expected ...
(Date:11/30/2015)...  HUYA Bioscience International, the leader in accelerating global ... today announced it has signed a Memorandum of Understanding ... collaboration between KDDF and HUYA with the ultimate goal ... for the global market. China,s ... innovative preclinical and clinical stage compounds. The company advances ...
(Date:11/30/2015)... and MAGDEBURG, Germany , November 30, 2015 ... in Vienna, Austria to be ... of NeuroRehabilitation (ECNR) in Vienna, Austria ... NovaVision, a wholly owned subsidiary of Vycor Medical, Inc. ("Vycor") ... its Internet-delivered NovaVision Therapy Suite at the 3rd European ...
Breaking Biology Technology:
(Date:11/10/2015)... 2015  In this report, the biomarkers ... product, type, application, disease indication, and geography. ... are consumables, services, software. The type segments ... efficacy biomarkers, and validation biomarkers. The applications ... development, drug discovery and development, personalized medicine, ...
(Date:11/9/2015)... DUBLIN , Nov. 09, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) ...
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
Breaking Biology News(10 mins):